[HTML][HTML] Circular RNAs: Characterization, cellular roles, and applications

CX Liu, LL Chen - Cell, 2022 - cell.com
Most circular RNAs are produced from the back-splicing of exons of precursor mRNAs.
Recent technological advances have in part overcome problems with their circular …

Nanotechnology-based mRNA vaccines

S Chen, X Huang, Y Xue, E Álvarez-Benedicto… - Nature Reviews …, 2023 - nature.com
Abstract mRNA vaccines have emerged as a revolutionary tool to generate rapid and
precise immune responses against infectious diseases and cancers. Compared with …

[PDF][PDF] Drug allergy: a 2022 practice parameter update

DA Khan, A Banerji, KG Blumenthal, EJ Phillips… - Journal of Allergy and …, 2022 - Elsevier
Resolving conflict of interest The Joint Task Force on Practice Parameters (JTFPP) is
committed to ensuring that all guidelines are based on the best scientific evidence at the …

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases

DE McMahon, E Amerson, M Rosenbach… - Journal of the American …, 2021 - Elsevier
Background Cutaneous reactions after messenger RNA (mRNA)-based COVID-19 vaccines
have been reported but are not well characterized. Objective To evaluate the morphology …

[HTML][HTML] Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers

RAK Kadali, R Janagama, S Peruru… - International Journal of …, 2021 - Elsevier
Introduction Concerns are prevailing about the safety and side effects of the BNT162b2
mRNA vaccine for coronavirus disease 2019 (COVID-19). Methods A randomized, cross …

[HTML][HTML] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions

AI Abulsoud, HM El-Husseiny, AA El-Husseiny… - Biomedicine & …, 2023 - Elsevier
COVID-19 is a worldwide pandemic caused by SARS-coronavirus-2 (SARS-CoV-2). Less
than a year after the emergence of the Covid-19 pandemic, many vaccines have arrived on …

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines

J Szebeni, G Storm, JY Ljubimova, M Castells… - Nature …, 2022 - nature.com
After over a billion of vaccinations with messenger RNA-lipid nanoparticle (mRNA-LNP)
based SARS-CoV-2 vaccines, anaphylaxis and other manifestations of hypersensitivity can …

The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and …

M Greenhawt, EM Abrams, M Shaker, DK Chu… - The Journal of Allergy …, 2021 - Elsevier
Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) immunization efforts. We convened a multidisciplinary group of international …

Role of nanotechnology behind the success of mRNA vaccines for COVID-19

A Khurana, P Allawadhi, I Khurana, S Allwadhi… - Nano Today, 2021 - Elsevier
The emergency use authorization (EUA) by the US-FDA for two mRNA-based vaccines
BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) has brought hope of addressing …

[HTML][HTML] Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine

P Sellaturay, S Nasser, S Islam… - Clinical and …, 2021 - ncbi.nlm.nih.gov
To the Editor, On the first day of the UK vaccination campaign with the coronavirus disease
2019 (COVID-19) vaccine, there were reports of 2 cases of anaphylaxis within minutes of …